Cargando…
Correction: Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579544/ https://www.ncbi.nlm.nih.gov/pubmed/30885993 http://dx.doi.org/10.1136/annrheumdis-2015-208093corr1 |
Ejemplares similares
-
Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss
por: Krishnamurthy, Akilan, et al.
Publicado: (2016) -
Correction to: Comparing cost-utility of DMARDs in autoantibody-negative rheumatoid arthritis patients
por: Luurssen-Masurel, Nathalie, et al.
Publicado: (2022) -
Correction: Autoantibody Epitope Spreading in the Pre-Clinical Phase Predicts Progression to Rheumatoid Arthritis
por: Sokolove, Jeremy, et al.
Publicado: (2012) -
How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis
por: Steffen, Ulrike, et al.
Publicado: (2019) -
Correction: A Comprehensive Molecular Interaction Map for Rheumatoid Arthritis
por: Wu, Gang, et al.
Publicado: (2010)